Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
US |
|
T
|
Take-Two Interactive Software Inc
XMUN:TKE
|
US |
|
V
|
Vintcom Technology PCL
SET:VCOM
|
TH |
|
B
|
Bluebik Group PCL
SET:BBIK
|
TH |
|
Aeffe SpA
MIL:AEF
|
IT |
|
E
|
Energy Absolute PCL
SET:EA
|
TH |
|
F
|
Forth Smart Service PCL
SET:FSMART
|
TH |
|
P
|
Powerhouse Energy Group PLC
LSE:PHE
|
UK |
|
B
|
Ba Airport Leasehold Real Estate Investment Trust
SET:BAREIT
|
TH |
|
R
|
Ryanair Holdings PLC
F:RY4C
|
IE |
|
Ko Gold Inc
OTC:KOGDF
|
CA |
Intrinsic Value
Is VRTX undervalued or overvalued?
See the intrinsic value estimate for Vertex Pharmaceuticals Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
VRTX looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with VRTX’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Vertex Pharmaceuticals Does
Vertex Pharmaceuticals is a biotech company that discovers and sells prescription medicines for serious diseases. Its best-known business is cystic fibrosis treatment, where it develops drugs that help correct the underlying protein defect that causes the disease. It also works on medicines for pain, sickle cell disease, beta thalassemia, and other hard-to-treat conditions.
- Headquarters
- United States of America US
- Employees
- 6 400
- IPO date
- Jul 24, 1991
Revenue & Expenses Breakdown
Vertex Pharmaceuticals Inc
Earnings Waterfall
Vertex Pharmaceuticals Inc
The intrinsic value for Vertex Pharmaceuticals Inc (VRTX) under the Base Case is hidden USD.
Compared with the current market price of 510.065 USD, the stock appears hidden.